整合剂量学参数、临床因素与影像组学预测接受免疫联合放疗的肺癌患者症状性放射性肺炎
本研究回顾性收集73例既往接受免疫检查点抑制剂后行胸部放疗的肺癌患者数据,其中41例(56.2%)发生症状性≥2级放射性肺炎。研究结合临床/剂量学因素与手工及深度学习影像组学特征构建预测模型,最佳模型(HCR+ResNet+Clinical)在训练集和测试集的平均AUC分别为0.936和0.946,作者认为该模型对放射性肺炎具有高预测能力,值得进一步前瞻性验证。
要点
- 73例肺癌患者中41例(56.2%)发生症状性≥2级放射性肺炎。
- 融合手工与深度学习影像组学及临床剂量学特征的最佳模型平均AUC训练集0.936、测试集0.946。
- 作者认为该模型预测能力高,值得进一步前瞻性验证。
核心结论
- 在肺癌免疫联合放疗患者中,整合临床/剂量学因素与手工及深度学习影像组学特征对放射性肺炎具有高预测能力,值得进一步前瞻性验证。
研究设计与样本
- 本研究为回顾性研究,收集73例既往接受免疫检查点抑制剂后行胸部放疗的肺癌患者数据。
- 放射性肺炎按多学科临床共识依据CTCAE v5.0定义,症状性≥2级放射性肺炎41例(56.2%)。
- 感兴趣区包括大体肿瘤体积(GTV)、计划肿瘤体积(PTV)和PTV-GTV,从每个感兴趣区提取107个手工影像组学特征,并基于预训练3D残差网络模型提取深度学习影像组学特征。
- 构建手工影像组学模型、融合手工影像组学模型、融合手工+ResNet模型及融合手工+ResNet+临床模型,采用受试者工作特征曲线及曲线下面积(AUC)比较。
- 采用五折交叉验证以避免模型过拟合。
主要发现
- 各感兴趣区手工影像组学模型及融合手工影像组学模型预测能力良好,训练集AUC为0.740至0.808,测试集AUC为0.740至0.802。
- 加入深度学习影像组学特征改善了手工影像组学模型效果,训练集AUC为0.826至0.898,测试集AUC为0.821至0.898。
- 最佳预测模型(HCR+ResNet+Clinical)结合手工与深度学习影像组学特征及7个临床/剂量学特征,训练集平均AUC为0.936,测试集平均AUC为0.946。
局限性
- 原文结论指出该模型值得进一步前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to combine clinical/dosimetric factors and handcrafted/deep learning radiomic features to establish a predictive model for symptomatic (grade ≥ 2) radiation pneumonitis (RP) in lung cancer patients who received immunotherapy followed by radiotherapy. MATERIALS AND METHODS: This study retrospectively collected data of 73 lung cancer patients with prior receipt of ICIs who underwent thoracic radiotherapy (TRT). Of these 73 patients, 41 (56.2 %) developed symptomatic grade ≥ 2 RP. RP was defined per multidisciplinary clinician consensus using CTCAE v5.0. Regions of interest (ROIs) (from radiotherapy planning CT images) utilized herein were gross tumor volume (GTV), planning tumor volume (PTV), and PTV-GTV. Clinical/dosimetric (mean lung dose and V5-V30) parameters were collected, and 107 handcrafted radiomic (HCR) features were extracted from each ROI. Deep learning-based radiomic (DLR) features were also extracted based on pre-trained 3D residual network models. HCR models, Fusion HCR model, Fusion HCR + ResNet models, and Fusion HCR + ResNet + Clinical models were built and compared using the receiver operating characteristic (ROC) curve with measurement of the area under the curve (AUC). Five-fold cross-validation was performed to avoid model overfitting. RESULTS: HCR models across various ROIs and the Fusion HCR model showed good predictive ability with AUCs from 0.740 to 0.808 and 0.740-0.802 in the training and testing cohorts, respectively. The addition of DLR features improved the effectiveness of HCR models (AUCs from 0.826 to 0.898 and 0.821-0.898 in both respective cohorts). The best performing prediction model (HCR + ResNet + Clinical) combined HCR & DLR features with 7 clinical/dosimetric characteristics and achieved an average AUC of 0.936 and 0.946 in both respective cohorts. CONCLUSIONS: In patients undergoing combined immunotherapy/RT for lung cancer, integrating clinical/dosimetric factors and handcrafted/deep learning radiomic features can offer a high predictive capacity for RP, and merits further prospective validation.
引用
- Nie T, Chen Z, Cai J, et al. Integration of dosimetric parameters, clinical factors, and radiomics to predict symptomatic radiation pneumonitis in lung cancer patients undergoing combined immunotherapy and radiotherapy. Radiother Oncol. 2023. PMID: 38070685. doi:10.1016/j.radonc.2023.110047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。